Virtual Reality at End-of-life
The Impact of a Novel Virtual Reality Protocol on Presence and Symptom Severity at the End-of-life.
1 other identifier
interventional
9
1 country
1
Brief Summary
The purpose of this research is to determine the effect that repeated, personalized virtual reality experiences have on symptom severity, comparing self-reported symptom severity both pre and post each session, and overtime across sessions. Researchers will also determine if this intervention results in a high rating of presence in VR, and if presence is related to the magnitude of the change in symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 23, 2023
CompletedFirst Submitted
Initial submission to the registry
November 20, 2023
CompletedFirst Posted
Study publicly available on registry
November 29, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 15, 2024
CompletedDecember 19, 2024
December 1, 2024
9 months
November 20, 2023
December 16, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Edmonton Symptom Assessment System - Revised (ESAS)
End-of-life symptom assessment
Two weeks
Secondary Outcomes (1)
igroup presence questionnaire (IPQ)
Two weeks
Study Arms (1)
Single-Arm Open Pilot
EXPERIMENTALPre- Post-intervention design. The intervention that participants will be experiencing is personalized virtual reality experiences. The content of this experience will be determined at the initial visit during which the participant will complete a preference questionnaire which identifies the location they want to "go" to. These experiences will be filmed on the insta360 One R camera by the research coordinator. Each experience will be approximately 20 minutes. To view the videos participants will wear the Oculus Quest 2 virtual reality headset.
Interventions
The intervention that participants will be experiencing is personalized virtual reality experiences. The content of this experience will be determined at the initial visit during which the participant will complete a preference questionnaire which identifies the location they want to "go" to. These experiences will be filmed on the insta360 One R camera by the research coordinator. Each experience will be approximately 20 minutes. To view the videos participants will wear the Oculus Quest 2 virtual reality headset.
Eligibility Criteria
You may qualify if:
- Patients who are hospice care eligible as defined by the Medicare Hospice benefit and receive hospice or palliative care from Hospice and Palliative Care Buffalo.
You may not qualify if:
- Their Palliative Performance Score (PPS) is below 30.
- They are not cognitively intact (display symptoms of delirium or senility, or have a cognitive diagnosis such as Alzheimer's or Dementia) as measured by the Confusion Assessment Method (CAM) (Inouye et al., 1990)
- They have hearing, vision, or speech impairments that are uncorrected.
- They have current symptoms of or a history of dizziness, nausea, headaches, migraines, seizures, or motion sickness.
- They do not speak English.
- They are not 18 years old.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospice and Palliative Care Buffalo
Cheektowaga, New York, 14225, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Catherine Mann, EdD
SUNY Buffalo
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
November 20, 2023
First Posted
November 29, 2023
Study Start
October 23, 2023
Primary Completion
July 15, 2024
Study Completion
July 15, 2024
Last Updated
December 19, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share
Due to the sensitive nature of the study population at end-of-life and small sample size we feel that it poses undue risk for harm due to potential for anonymity being compromised.